A detailed history of Captrust Financial Advisors transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 3,360 shares of SRPT stock, worth $408,609. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,360
Previous 2,422 38.73%
Holding current value
$408,609
Previous $313,000 69.33%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $106,303 - $153,691
938 Added 38.73%
3,360 $530,000
Q1 2024

May 15, 2024

SELL
$93.7 - $141.53 $229,377 - $346,465
-2,448 Reduced 50.27%
2,422 $313,000
Q4 2023

Feb 14, 2024

SELL
$67.31 - $124.76 $53,376 - $98,934
-793 Reduced 14.0%
4,870 $469,000
Q3 2023

Nov 14, 2023

SELL
$102.5 - $123.59 $24,087 - $29,043
-235 Reduced 3.98%
5,663 $686,000
Q2 2023

Aug 14, 2023

SELL
$106.4 - $157.19 $87,886 - $129,838
-826 Reduced 12.28%
5,898 $675,000
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $92,025 - $122,140
783 Added 13.18%
6,724 $926,000
Q4 2022

Feb 15, 2023

BUY
$100.86 - $132.13 $217,151 - $284,475
2,153 Added 56.84%
5,941 $769,000
Q3 2022

Nov 16, 2022

BUY
$75.71 - $119.24 $24,000 - $37,799
317 Added 9.13%
3,788 $419,000
Q2 2022

Aug 23, 2022

SELL
$62.69 - $88.44 $3,949 - $5,571
-63 Reduced 1.78%
3,471 $260,000
Q2 2022

Aug 16, 2022

BUY
$62.69 - $88.44 $6,707 - $9,463
107 Added 3.12%
3,534 $265,000
Q1 2022

May 16, 2022

BUY
$63.15 - $90.42 $4,862 - $6,962
77 Added 2.3%
3,427 $268,000
Q4 2021

Feb 14, 2022

SELL
$77.28 - $99.42 $203,014 - $261,176
-2,627 Reduced 43.95%
3,350 $302,000
Q3 2021

Nov 16, 2021

SELL
$65.97 - $92.48 $43,870 - $61,499
-665 Reduced 10.01%
5,977 $553,000
Q2 2021

Aug 16, 2021

SELL
$69.38 - $86.75 $7,007 - $8,761
-101 Reduced 1.5%
6,642 $516,000
Q1 2021

May 17, 2021

SELL
$72.25 - $168.95 $10,259 - $23,990
-142 Reduced 2.06%
6,743 $503,000
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $8,789 - $12,511
-70 Reduced 1.01%
6,885 $1.17 Million
Q3 2020

Nov 17, 2020

SELL
$127.12 - $172.34 $27,330 - $37,053
-215 Reduced 3.0%
6,955 $984,000
Q2 2020

Aug 14, 2020

SELL
$93.0 - $171.7 $385,485 - $711,696
-4,145 Reduced 36.63%
7,170 $1.19 Million
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $63,020 - $100,704
-765 Reduced 6.33%
11,315 $1.05 Million
Q4 2019

Feb 14, 2020

BUY
$76.53 - $135.58 $924,482 - $1.64 Million
12,080 New
12,080 $1.56 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.6B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.